➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Express Scripts
Medtronic
McKesson
Harvard Business School

Last Updated: September 25, 2020

DrugPatentWatch Database Preview

METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Metoprolol Tartrate And Hydrochlorothiazide patents expire, and when can generic versions of Metoprolol Tartrate And Hydrochlorothiazide launch?

Metoprolol Tartrate And Hydrochlorothiazide is a drug marketed by Alembic Pharms Ltd, Mylan, and Sun Pharm Inds. and is included in three NDAs.

The generic ingredient in METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; metoprolol tartrate. There are thirty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; metoprolol tartrate profile page.

Summary for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE
Drug patent expirations by year for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE
Recent Clinical Trials for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mylan PharmaceuticalsPhase 1
Vanderbilt University Medical CenterPhase 1/Phase 2

See all METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE clinical trials

Pharmacology for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE

US Patents and Regulatory Information for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alembic Pharms Ltd METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; metoprolol tartrate TABLET;ORAL 202870-001 Nov 6, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; metoprolol tartrate TABLET;ORAL 090654-001 Jan 19, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; metoprolol tartrate TABLET;ORAL 076792-001 Aug 20, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; metoprolol tartrate TABLET;ORAL 090654-002 Jan 19, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
Alembic Pharms Ltd METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; metoprolol tartrate TABLET;ORAL 202870-002 Nov 6, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
Alembic Pharms Ltd METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; metoprolol tartrate TABLET;ORAL 202870-003 Nov 6, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; metoprolol tartrate TABLET;ORAL 076792-003 Aug 20, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Baxter
Dow
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.